Japan high court favours DSP in quinolone case
This article was originally published in Scrip
Executive Summary
Dainippon Sumitomo Pharma (DSP) has won the latest round in a legal battle with fellow Japanese company Wakunaga Pharmaceutical over a terminated 1998 licensing deal for a quinolone antibacterial.